{"Ticker": "VTRS", "Company": "Viatris", "Sector": "Health Care", "Updated": "2022-11-10", "Rating": [{"Date": "2022-11-10", "Rating": "Upgrade", "Organization": "UBS", "Rating_Change": "Sell to Neutral", "Target_Change": "$9 to $12"}, {"Date": "2022-11-08", "Rating": "Upgrade", "Organization": "Piper Sandler", "Rating_Change": "Underweight to Neutral", "Target_Change": "$10"}, {"Date": "2022-10-21", "Rating": "Resumed", "Organization": "Jefferies", "Rating_Change": "Hold", "Target_Change": "$11"}, {"Date": "2022-06-14", "Rating": "Initiated", "Organization": "UBS", "Rating_Change": "Sell", "Target_Change": "$9"}, {"Date": "2022-05-10", "Rating": "Downgrade", "Organization": "Piper Sandler", "Rating_Change": "Neutral to Underweight", "Target_Change": "$10"}, {"Date": "2022-03-01", "Rating": "Downgrade", "Organization": "Raymond James", "Rating_Change": "Outperform to Mkt Perform", "Target_Change": ""}, {"Date": "2022-03-01", "Rating": "Downgrade", "Organization": "BofA Securities", "Rating_Change": "Buy to Neutral", "Target_Change": "$21 to $13"}, {"Date": "2021-06-15", "Rating": "Initiated", "Organization": "Citigroup", "Rating_Change": "Neutral", "Target_Change": "$16"}, {"Date": "2021-04-07", "Rating": "Resumed", "Organization": "RBC Capital Mkts", "Rating_Change": "Outperform", "Target_Change": "$24"}, {"Date": "2021-03-08", "Rating": "Downgrade", "Organization": "Goldman", "Rating_Change": "Buy to Neutral", "Target_Change": "$20 to $15"}, {"Date": "2021-03-02", "Rating": "Downgrade", "Organization": "JP Morgan", "Rating_Change": "Overweight to Neutral", "Target_Change": "$21 to $18"}, {"Date": "2021-02-26", "Rating": "Downgrade", "Organization": "Wolfe Research", "Rating_Change": "Outperform to Peer Perform", "Target_Change": "$17"}, {"Date": "2021-01-05", "Rating": "Initiated", "Organization": "Argus", "Rating_Change": "Hold", "Target_Change": ""}, {"Date": "2020-12-14", "Rating": "Initiated", "Organization": "Bernstein", "Rating_Change": "Mkt Perform", "Target_Change": "$21"}]}